Ashanthi Mathai is an accomplished professional in the pharmaceutical and medical device development sector, currently holding a key position at Serendib LLC since June 2024. As a board member for Care For Lanka and a member of StartX since May 2022 and October 2019 respectively, Ashanthi contributes to initiatives that support entrepreneurship and healthcare innovation. Previously, Ashanthi co-founded and served as CEO of Pocket Naloxone Corp., which focused on making Naloxone more accessible for opioid overdose reversal. Ashanthi also founded IANA Health, LLC, aimed at addressing substance use disorders through a digital health platform, and held various marketing and leadership roles in notable organizations including Specialists On Call, U.S. Pharmacopeia, and Otsuka America Pharmaceutical. Academic credentials include an MBA from the Stanford University Graduate School of Business, an MS in Chemical Engineering from Stanford University, and a BSE in Chemical Engineering from Princeton University, graduating summa cum laude.
This person is not in the org chart
This person is not in any teams
This person is not in any offices